Pheramor, the initial product of a technology platform company X&Y Technologies, is a genetic-based dating app that sequences your HLA genes to help you get better matches. You have the opportunity to share your data with non-profits, like Gift of Life, but are not obligated and Pheramor does not sell your genetic data.
Check out the 1-minute video that aired on KHOU 11 today by clicking here.
X&Y Technologies (Pheramor) has been a GOOSE portfolio company since 2017 when GOOSE, along with HAN and other Houston investors, participated in the pre-seed financing. Brittany Baretto, co-founder and CEO, has her Ph.D. from Baylor College of Medicine and found GOOSE by taking Jack Gill‘s class at Rice University. Bin Huang, co-founder and CTO, received his doctorate from Rice University.
The company is currently raising their next round of financing. Email CEO Brittany Baretto for more information: firstname.lastname@example.org
Saranas Inc, a GOOSE portfolio company and Houston-based medical device startup, recently closed a round of $2.8 million to kick off clinical trails for their Early Bird Bleed Monitoring System. This round brings their total funding to $12 million.
Early Bird Bleed Monitoring System, invented by Dr. Mehdi Razavi at the Texas Heart Institute, is meant to detect bleeding complications during procedures. The company anticipates FDA approval in early 2019.
GOOSE Portfolio Company and Houston based start-up, Fluidity, officially launched last week right in time for the Holiday season!
Fluidity is revolutionizing drone control and their first product is the FT Aviator: a game-changing drone controller designed by former NASA astronaut, Scott Parazynski and a team of Rice MBA’s. The controller is an intuitive, single-handed design that eliminates the complexity of dual thumb controllers, has advanced camera controls for high-quality photo and video capture, and is compatible with most DJI drones.
Out of the eight companies presenting GOOSE heard from many different verticals located in 4 different geographies, including Silicon Valley,China, and of course, Houston. The industries presented were consumer electronics, artificial intelligence, robotics, medical devices, and lastly manufacturing in specialty chemicals. The GOOSE Society was pleased to have hosted Forest Devices, the 2017 Rice Business Plan Competition (RBPC) winner that is working towards the better treatment of stroke patients with their device, AlphaStroke. The group also heard from the two GOOSE Society Prize winners of the Texas A&M New Ventures Competition, Arovia and M&S Biotics.
The special attendees were Gina Luna & Russ Capper who represented Houston Exponential (HX), an independent 501C-3 organization that supports the growth of the Houston innovation economy. HX leads on the opportunities that require collaboration across the ecosystem, champions the ecosystem by telling the innovation story of the region and its firms, and it builds and attracts the resources the innovation economy needs to thrive. Along with strong momentum powered by fourteen working groups operated with over two-hundred active volunteers from over fifty major corporations, HX has achieved a major milestone with its new innovation district. This 9.4 acre, $100 million redevelopment by Rice University of the Sears building in Midtown is expected to be complete in two years and will bring a district of dense, mixed used space that attracts talent and creates collisions among entrepreneurs, investors, academics and other ecosystem players.
The Texas Medical Center, Houston – TMC is the world’s largest medical center with over 100,000 employees and 170,000 operations performed each year. With a center larger than even the 2nd and 3rd medical centers combined, it has never been faster and easier to drive from lab research to operation room in minutes.
TMCx is an accelerator that aims “to advance the development of health and medical technology companies by connecting visionary entrepreneurs to the abundant resources of the Texas Medical Center.”
Yesterday TMCx hosted the 2018 Digital Health Demo Day. Prior to the start of the pitches, the room was filled with excitement and anticipation as the young companies prepared themselves to stand before what Tim Buffet (TMCx Advisor) called “record breaking crowds.” The TMCx Digital Health Demo Day hit a record number of 824 registered attendees with 500 viewers on the live webcast. Buffet added “It has been very cool to watch the companies’ ideas grow into something spectacular like this.”
One of the attendees noted how exciting it is to see such forward looking technologies and technology companies plugging into the Houston ecosystem. One of those such companies, Particle Health (New York), is a blockchain-based consent management platform which enables a radical new way to securely facilitate the exchange of healthcare information across institutions.
Particle Health addresses a current challenge: clinical health data is siloed behind a healthcare organization’s inundated administers and technology stacks, and this is becoming an increasingly expensive and time-consuming process.
Their solution puts the patient at the center of the authorization process, allowing them to manage the consent of what and to whom their data can be shared. With patients engaged, this platform enables healthcare organizations to regulate the access to their patient’s data securely and efficiently.
Here, blockchain is key. It allows for Particle Health to automate the sharing of granular information individually, securely, and anonymously without the need for a ‘middle-man’ and immutably track each transaction.
Overall, TMCx Digital Health 2018 was a spectacular experience that not only drew in life science individuals and investors, but any individuals or investors who enjoy hearing brain stimulating pitches and learning about the cutting edge technology coming out of Houston.
Congratulations to all of the teams and to TMCx for another successful accelerator class – we are all excited to watch these companies continue their growth.
Here are the rest of the startup companies that presented Thursday afternoon:
Abaka Health (San Francisco) – Abaka Health helps providers create a better end-to-end patient experience by bringing together the clinical and financial aspects of health care into one easy-to-use platform.
Agathos (San Francisco) – Reduces unnecessary variation in hospital care via individualized metrics, actionable feedback and physician-led behavior change.
B.Well (Baltimore) – Empowering consumers by aggregating their health care data by providing incentivized care coordination, along with concierge and matching services.
Deep 6 AI (Pasadena California) – Using artificial intelligence on clinical data to increase the quantity, and find better-matched patients, for clinical trials in minutes, instead of months.
Dermasenor (Miami) – Connected device enabling health care professionals and patients to efficiently check for skin cancer by leveraging cutting-edge technologies.
Evidence Care (Nashville, Tennessee) – Clinical decision support tool that allows providers to access evidence-based treatment recommendations that are patient-focused, enhance the shared decision-making process and accelerate their EHR workflow.
Gain Life (Boston) – Digital platform using personalized and adaptive behavior change programs to engage indivudals in achieving better outcomes.
KlitKit (Denmark) – Smart button and application that monitors, analyzes and improves habits and behaviors.
Luminare (Houston) – Anti-sepsis SaaS incorporating behavioral change and intelligent medical record augmentation.
NarrativeDx (Austin) – Artifical intelligence platform identifying insights from patient feedback to improve CAHPS scores, increase referrals and reduce nurse turnover.
Orintel (Houston) – Hardware and software solutions providing operational support and real-time OR status to deliver a more cost-effective surgical suite to staff and patients.
Patients We Share (Houston) – Workflow communication application using machine learning to foster connectivity within the health care ecosystem, aligning patients with the most appropriate providers, product and services.
Revealix (Austin) – Innovative medical imaging software service pioneering early discovery of diabetic limb complications which is non-invasive, mobile and at the point-of-care.
ScalaMed (Australia) – Blockchain prescription solution which re-routes prescriptions to the patient, creating engaged, empowered, and educated patients, and allowing patients to choose a pharmacy based on convenience and value.
ScenceTech (Austin) – Autonomous, continuous monitoring electrocardiogram and heart rate variability bracelet using a proprietary ECG/HRV cloud-based interpretation platform.
Softcare Studios (Italy) – Immersive virtual reality experiences aimed at improving the well-being of patients undergoing painful and anxiety-provoking procedures during therapy.
Strados Labs (Philadelphia, PA) – Continuous breathing sensor that connects doctors with asthma and COPD patients to improve care management and remote patient monitoring.
Sunrise Health (Boston) – Text-based group support for behavioral health patients utilizing artificial intelligence tools to increase provider capacity and catch complications early.
Trayt (Redwoods City, California) – Data collection and analytics company providing insights and a daily road map to improve diagnosis, treatments and quality of life for patients with brain disorders.
Trusted Health (San Francisco) – Opportunity platform for the modern nurse, connecting top RNs to flexible nursing jobs at innovative employers.
Well Health (Santa Barbara, California) – An intuitive two-way texting platform for front office and patients that eliminates phone tag and improves the health care experience.